chr1-215782759-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 4P and 3B. PM1PM2BP4_ModerateBP6
The NM_206933.4(USH2A):āc.10564A>Gā(p.Arg3522Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000159 in 1,613,766 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_206933.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
USH2A | NM_206933.4 | c.10564A>G | p.Arg3522Gly | missense_variant | 53/72 | ENST00000307340.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
USH2A | ENST00000307340.8 | c.10564A>G | p.Arg3522Gly | missense_variant | 53/72 | 1 | NM_206933.4 | P1 | |
USH2A | ENST00000674083.1 | c.10564A>G | p.Arg3522Gly | missense_variant | 53/73 |
Frequencies
GnomAD3 genomes AF: 0.000230 AC: 35AN: 152234Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000108 AC: 27AN: 251136Hom.: 0 AF XY: 0.0000958 AC XY: 13AN XY: 135730
GnomAD4 exome AF: 0.000151 AC: 221AN: 1461532Hom.: 0 Cov.: 31 AF XY: 0.000171 AC XY: 124AN XY: 727078
GnomAD4 genome AF: 0.000230 AC: 35AN: 152234Hom.: 0 Cov.: 33 AF XY: 0.000242 AC XY: 18AN XY: 74376
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jan 15, 2016 | The p.Arg3522Gly variant in USH2A has not been previously reported in individual s with hearing loss or Usher syndrome, but has been identified 11/66536 European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitu te.org; dbSNP rs147374057). Although this variant has been seen in the general p opulation, its frequency is not high enough to rule out a pathogenic role. Compu tational prediction tools and conservation analyses suggest that the p.Arg3522Gl y variant may not impact the protein, though this information is not predictive enough to rule out pathogenicity. In summary, the clinical significance of t he p.Arg3522Gly variant is uncertain. - |
Usher syndrome type 2A;C3151138:Retinitis pigmentosa 39 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
Usher syndrome type 2A Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Nov 06, 2019 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 24, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at